• Aleksi Šedo
    Biomedical science is trying to find ways to help patients whom clinical medicine so far cannot help.
    Aleksi Šedo
  • Ondřej Slabý
    Cancer research that really helps is always based on intensive interdisciplinary collaboration.
    Ondřej Slabý
  • Marián Hajdúch
    Our research teams make constant, incremental progress in both diagnosing and treating cancers – and they will never give up in fighting this enemy.
    Marián Hajdúch
3nodes

Prague, Brno, Olomouc

5

research programmes

11

research institutes

71

research teams

1shared goal

progress in the fight against cancer

Details

About us

Research of cancers represents about 25% of all biomedical research in the Czech Republic. It is an area that has a long tradition in our country and its current results are, in international comparison, above the average.

Details

Newsletter subscription

If you would like to subscribe to our newsletter, please email us HERE.

News and announcements

9. 12. 2025

Czech Science Grows When Forces Are Joined

On 2 December 2025, a summary conference of the collaborating EXCELES projects was held at the Residence of the Mayor of Prague. EXCELES is a programme of the Ministry of Education, Youth and Sports aimed at supporting excellent research and the emergence of national scientific authorities. Funded by the National Recovery Plan, the projects connect key biomedical institutions across the Czech Republic and strive for what Czech research has long been lacking: cooperation rather than fragmentation.
Líbí se?
Read more
3. 12. 2025

CACR 2025: From Basic Cancer Research to the Patient’s Bedside

The programme of this year’s Czech Annual Cancer Research Meeting (CACR Meeting), which brought almost 300 leading scientists from the Czech Republic and abroad to Olomouc on 23–25 November, offered a comprehensive overview of the latest findings that may fundamentally influence future cancer prevention, diagnosis, and treatment. The National Institute for Cancer Research (ICR) also presented the results of its 3.5-year existence.
Líbí se?
Read more

Collaboration

In addition to several large European and Czech scientific infrastructures, the National Institute for Cancer Research will also cooperate with various university hospitals, pharmaceutic or biotechnological companies, patient organisations, and other partners.

Details